Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression

Xiaofei Wu1, Zhichao Chen, Zhongping Liu

  • 1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Arsenic trioxide inhibits chronic myeloid leukemia (K562) cell growth by arresting the cell cycle at the G2/M phase. Increased Survivin expression may contribute to K562 cells resistance to arsenic trioxide-induced apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm.
  • Arsenic trioxide (As2O3) is a chemotherapeutic agent with demonstrated efficacy in certain leukemias.
  • Survivin is an inhibitor of apoptosis protein (IAP) implicated in cancer cell survival and drug resistance.

Purpose of the Study:

  • To elucidate the mechanisms by which As2O3 inhibits K562 cell proliferation.
  • To investigate the role of Survivin in As2O3-induced apoptosis in K562 cells.

Main Methods:

  • K562 cells were treated with varying concentrations of As2O3.
  • Cell proliferation was assessed using MTT assay.
  • Cell cycle distribution and apoptosis were analyzed by flow cytometry.
  • Survivin protein and mRNA expression were quantified via flow cytometry and RT-PCR, respectively.

Main Results:

  • As2O3 (2-10 micromol/L) significantly inhibited K562 cell growth without inducing substantial apoptosis.
  • A dose-dependent increase in G2/M phase cell cycle arrest was observed with As2O3 treatment.
  • Survivin mRNA and protein expression were upregulated in response to As2O3 exposure.

Conclusions:

  • As2O3 inhibits K562 cell proliferation primarily through G2/M phase cell cycle arrest.
  • Upregulation of Survivin may confer resistance to As2O3-induced apoptosis in K562 cells, suggesting a potential therapeutic target.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...